vol21no7_pdf-version

Parechovirus Genotype 3 Outbreakamong Infants, New South Wales,Australia, 2013–2014Germaine Cumming, 1 Ameneh Khatami, Brendan J. McMullan, Jennie Musto, Kit Leung,Oanh Nguyen, Mark J. Ferson, Georgina Papadakis, Vicky SheppeardMedscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowingclinicians the opportunity to earn CME credit.This activity has been planned and implemented in accordance with the Essential Areas and policies of theAccreditation Council for Continuing Medical Education through the joint providership of Medscape, LLC andEmerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical educationfor physicians.Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1Credit(s) TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.All other clinicians completing this activity will be issued a certificate of participation. To participate in this journalCME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take thepost-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; (4)view/print certificate.Learning ObjectivesUpon completion of this activity, participants will be able to:Release date: June 15, 2015; Expiration date: June 15, 20161. Describe the clinical and epidemiologic features of an HPeV3 outbreak among Australian infants2. Compare the presentation of the HPeV3 outbreak in Australia with that in the northern hemisphere3. Determine the efficacy of active surveillance in detecting and monitoring the HPeV3 outbreakamong Australian infants.CME EditorP. Lynne Stockton, VMD, MS, ELS(D), Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: P. LynneStockton, VMD, MS, ELS(D), has disclosed no relevant financial relationships.CME AuthorLaurie Barclay, MD, freelance writer and reviewer, Medscape, LLC. Disclosure: Laurie Barclay, MD, has disclosedno relevant financial relationships.AuthorsDisclosures: Germaine Cumming, MPHN; Ameneh Khatami, BHB, MB ChB, DipPaeds, MD; Brendan J.McMullan, BMed(Hons), DTMH, DCH, FRACP, FRCPA; Jennie Musto, Dip.App.Sci (Nursing), Grad.Dip.ClinicalNursing, MPH; Kit Leung, MIPH; Oanh Nguyen, MD, MCH; Mark J. Ferson, MBBS, MPH, MD, FRACP, FAFPHM,FRSPH; Georgina Papadakis, BSc; and Vicky Sheppeard, MBBS, MPH(Hons), FAFPHM, have disclosed norelevant financial relationships.Author affiliations: Health Protection New South Wales, Sydney,New South Wales, Australia (G. Cumming, J. Musto,V. Sheppeard); New South Wales Ministry of Health, Sydney(G. Cumming, K. Leung); The Children’s Hospital at Westmead,Sydney (A. Khatami); Sydney Children’s Hospital, Sydney(B.J. McMullan); University of New South Wales, Sydney(B.J. McMullan, M.J. Ferson); Western Sydney Local HealthDistrict, Sydney (O. Nguyen); South Eastern Sydney Local HealthDistrict, Sydney (M.J. Ferson); Victorian Infectious DiseaseReference Laboratory, Melbourne, Victoria, Australia (G. Papadakis)DOI: http://dx.doi.org/10.3201/eid2107.1411491Current affiliation: Independent consultant, Freshwater, NewSouth Wales, Australia1144 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015